[
  {
    "ts": "2025-05-30T04:46:01+00:00",
    "headline": "Charles River Laboratories International, Inc. (CRL): A Bull Case Theory",
    "summary": "We came across a bullish thesis on Charles River Laboratories International, Inc. (CRL) on scuttleblurb’s Substack. In this article, we will summarize the bulls’ thesis on CRL. Charles River Laboratories International, Inc. (CRL)’s share was trading at $136.25 as of 28th May. CRL’s trailing and forward P/E were 25.07 and 14.41 respectively according to Yahoo Finance. Life […]",
    "url": "https://finance.yahoo.com/news/charles-river-laboratories-international-inc-044601553.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "225d7261-5d5e-3a20-9c5b-8a665a452456",
      "content": {
        "id": "225d7261-5d5e-3a20-9c5b-8a665a452456",
        "contentType": "STORY",
        "title": "Charles River Laboratories International, Inc. (CRL): A Bull Case Theory",
        "description": "",
        "summary": "We came across a bullish thesis on Charles River Laboratories International, Inc. (CRL) on scuttleblurb’s Substack. In this article, we will summarize the bulls’ thesis on CRL. Charles River Laboratories International, Inc. (CRL)’s share was trading at $136.25 as of 28th May. CRL’s trailing and forward P/E were 25.07 and 14.41 respectively according to Yahoo Finance. Life […]",
        "pubDate": "2025-05-30T04:46:01Z",
        "displayTime": "2025-05-30T04:46:01Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/9566e54eafdb7eb193f977b607cfa6dd",
          "originalWidth": 768,
          "originalHeight": 430,
          "caption": "Is Repligen Corporation (RGEN) the Top Stock to Buy According to 12 West Capital Management?",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vQGOaYfjwcHxFPAHM8OB7Q--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/9566e54eafdb7eb193f977b607cfa6dd.cf.webp",
              "width": 768,
              "height": 430,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iZfaPbaIqB9wqu1bREC1hw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/9566e54eafdb7eb193f977b607cfa6dd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-laboratories-international-inc-044601553.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-laboratories-international-inc-044601553.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]